SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-036730
Filing Date
2019-06-13
Accepted
2019-06-13 16:08:18
Documents
1
Period of Report
2019-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4229
  Complete submission text file 0001209191-19-036730.txt   5624
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O APOLLO ENDOSURGERY, INC., 1120 S. CAPITAL OF TEXAS HWY, BLDG. 1, SUITE 300 AUSTIN TX 78746
Business Address
McClellan William D. Jr. (Reporting) CIK: 0001689402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37785 | Film No.: 19896188